<?xml version='1.0' encoding='utf-8'?>
<rss version="2.0">
	<channel>
		<title>OOIR Trends: Clinical Medicine (Integrative &amp; Complementary Medicine)</title>
		<description>Aktuelle Paper-Trends im Bereich Clinical Medicine (Integrative &amp; Complementary Medicine) von OOIR (mit Titel und Metadaten von Crossref)</description>
		<link>https://ooir.org</link>
		<language>en-us</language>
		<pubDate>Fri, 24 Oct 2025 00:59:11 GMT</pubDate>
		<lastBuildDate>Fri, 24 Oct 2025 00:59:11 GMT</lastBuildDate>
		<item>
			<title>Impact of Preoperative Progressive Relaxation Exercises on Postoperative Pain, Comfort, and Recovery</title>
			<link>https://doi.org/10.1097/hnp.0000000000000702</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 361
Autoren: Nurşen Kulakaç, Aylin Aydın Sayılan
Journal: Holistic Nursing Practice
Veröffentlicht: 2025-10-17
Abstract: 
                    
                    
                      This randomized controlled trial aimed to investigate the impact of preoperative progressive relaxation exercises on postoperative pain, comfort, and quality of recovery. The study was conducted between June and November 2023, involving 68 patients undergoing surgical intervention and hospitalized in the surgical clinic. Data were collected using the Personal Information Form, the Visual Analog Scale (VAS)-Pain, the Perianesthesia Comfort Scale, and the Quality of Recovery Questionnaire. At the sixth postoperative hour, no significant difference was observed in pain levels between the experimental and control groups (
                      P
                      &amp;gt; .05). However, the VAS scores for the experimental group at the 12th and 24th postoperative hours were significantly lower than those of the control group (
                      P
                      &amp;lt; .001). Furthermore, 24 hours postoperatively, the experimental group demonstrated significantly higher quality of recovery (
                      P
                      &amp;lt; .001) and comfort levels (
                      P
                      &amp;lt; .001) than the control group. This study concludes that patients engaged in relaxation exercises exhibited lower VAS scores and higher levels of recovery and comfort.
                    
                  
DOI: 10.1097/hnp.0000000000000702
ISSN: 0887-9311
Tag der Erhebung (OOIR): 2025-10-24</description>
			<guid isPermaLink="false">ooir-trend-10.1097/hnp.0000000000000702-2025-10-24-1</guid>
			<pubDate>Fri, 17 Oct 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Laboratory cultivated Cordyceps militaris modulates cockroach allergen-induced inflammation in keratinocytes and macrophages dual cell platforms</title>
			<link>https://doi.org/10.1186/s12906-025-05132-1</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 22
Autoren: Mey-Fann Lee, Jane-Yii Wu, Chi-Sheng Wu, Ching-Chun Lin, Yu-Wen Chu
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-10-15
DOI: 10.1186/s12906-025-05132-1
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-10-24</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05132-1-2025-10-24-2</guid>
			<pubDate>Wed, 15 Oct 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Efficacy and safety of Shugan Jieyu capsules in combination with zolpidem for insomnia disorder with depressive symptoms: a double-blind randomized controlled trial</title>
			<link>https://doi.org/10.1186/s12906-025-05142-z</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 22
Autoren: Qianqian Xin, Dhirendra Paudel, Jiehan Zhang, Huafeng Wei, Yihong Cheng, Yan Xu, Ruichen Fang, Jinnong Jiang, Yuling Wang, Bin Zhang
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-10-17
DOI: 10.1186/s12906-025-05142-z
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-10-24</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05142-z-2025-10-24-3</guid>
			<pubDate>Fri, 17 Oct 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Inhibitory effect of [6]-shogaol against 3CLpro activity and SARS-CoV-2 infection</title>
			<link>https://doi.org/10.1186/s12906-025-05094-4</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 21
Autoren: Takashi Tanikawa, Tsuyoshi Hayashi, Yuka Kiba, Hitoshi Kamauchi, Yuichi Someya, Masashi Kitamura
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-10-17
DOI: 10.1186/s12906-025-05094-4
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-10-24</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05094-4-2025-10-24-4</guid>
			<pubDate>Fri, 17 Oct 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>The effect of Citrus aurantium inhalation aromatherapy on chemotherapy-induced nausea and vomiting in breast cancer patients: a randomized controlled trial</title>
			<link>https://doi.org/10.1186/s12906-025-05052-0</link>
			<description>Feld: Clinical Medicine
Kategorie: Integrative &amp; Complementary Medicine
Score: 15
Autoren: Parsa Tabei, Zahra Molazem, Mozhgan Rivaz, Parvin Ghaem Maghami, Niloofar Ahmadloo
Journal: BMC Complementary Medicine and Therapies
Veröffentlicht: 2025-10-07
Abstract: Abstract
          
            Background
            Breast cancer (BC) is the second most common cancer globally and the most prevalent among women. Chemotherapy, a primary treatment, frequently induces distressing side effects like nausea and vomiting. This study evaluated the efficacy of Citrus aurantium inhalation aromatherapy in reducing chemotherapy-induced nausea and vomiting (CINV) in women with BC.
          
          
            Methods
            In this CONSORT-compliant parallel-group randomized controlled trial (registered at IRCT: 20240305061177N1), 92 BC patients at Motahari Clinic were randomly allocated (between April to August 2024) to an aromatherapy group (n = 46) or a control group (n = 46). Alongside standard antiemetic medications, the aromatherapy group inhaled two drops of C. aurantium essential oil applied to the philtrum, while the control group received sunflower oil. The Rhodes Index assessed nausea, vomiting, and retching over five days.
          
          
            Results
            Significant reductions in mean total scores for nausea, vomiting, and retching were observed in the aromatherapy group compared to the control group from days 3 to 5 (P &amp;lt; 0.05), with no significant differences on days 1 and 2. Total symptom scores significantly decreased from Day 1 to Day 5 in the aromatherapy group while the control group showed no change.
          
          
            Conclusion
            C. aurantium aromatherapy significantly alleviated CINV during the delayed phase (days 3–5). Given its safety, affordability, and accessibility, this intervention offers a promising complementary approach for managing CINV in BC patients.
          
          
            Trial registration
            This trial was registered with the Iranian Registry of Clinical Trials (IRCT20240305061177N1, march 17, 2024).
          
DOI: 10.1186/s12906-025-05052-0
ISSN: 2662-7671
Tag der Erhebung (OOIR): 2025-10-24</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s12906-025-05052-0-2025-10-24-5</guid>
			<pubDate>Tue, 07 Oct 2025 00:00:00 GMT</pubDate>
		</item>
	</channel>
</rss>